Diagnostyka S.A.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-09-02
Share capital
33,756,500.00 PLN
Activity description

Diagnostyka is a medical laboratory company that offers blood tests, allergy tests, genetic testing, and prenatal testing, with the option for home sample collection. They provide online results and free interpretation of test results, along with various health packages available for purchase. The company also emphasizes preventive health measures and offers consultations through their updated application.

Registered address
ul. Prof. Michała Życzkowskiego 16, 31-864 Kraków, Poland
Website
Opening hours
Mon–Fri
7:00–20:00
Sat
7:00–13:00
Email
Phone
Social media
Electronic delivery address
AE:PL-12592-53112-VFETU-15

Financials

Revenue history (in m)

Filing timeliness

3 of 5 financial statements were filed late (the longest delay 9 days for 2022). All were audited by a statutory auditor.

  • 202516/07/2026
  • 202401/07/2025
  • 202316/07/2024
  • 202224/07/2023
  • 202104/07/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 151.00
-2.60 (-1.69%)
151.00152.00153.00154.00155.00151.0010:0012:0014:0016:00
Open
PLN 154.10
High
PLN 154.80
Low
PLN 151.00
Volume
27.89K
Avg. vol.
29.08K
Market cap
PLN 5.1B
P/E ratio
20.00
EPS
PLN 7.55
Shares outstanding
33.76M
52-week
PLN 144.10 – 156.70
Dividend yield
2.91%
Dividend
PLN 4.40
Ex dividend date
Jun 1, 2026
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 184.50mUSD 25.68mUSD 15.50m
Q1 2026USD 181.23mUSD 33.24mUSD 22.30m
Q4 2025USD 155.27mUSD 16.82mUSD 9.26m
Q3 2025USD 153.78mUSD 25.29mUSD 19.60m

Results for Q3 2026:Nov 26, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Human health activities1 / 2,925
Top <1%
Top <1%
City · Kraków10 / 16,145
Top <1%
Voivodeship · Małopolskie21 / 27,724
Top <1%
Country · Poland304 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 609.61mMedianUSD 92.20kAverageUSD 1.38m
Net profit
This companyUSD 65.76mMedianUSD 2.70kAverageUSD 146.13k
Operating costs
This companyUSD 512.69mMedianUSD 82.92kAverageUSD 1.18m
Assets
This companyUSD 519.72mMedianUSD 39.12kAverageUSD 951.21k

Offer

Websites

The company has 9 websites. Most of them run on WordPress. The sites are available in: Polish and English. The company measures traffic with Google Analytics and uses the Meta advertising pixel (Facebook, Instagram).

  • diag.plDiagnostyka Laboratoria Medyczne | Badania krwi | Wyniki online
    Google Tag Manager
  • badaniakrwi.plBadania krwi
    WordPress 3.7ElementorGoogle Tag ManagerYoast SEOLiteSpeed
  • badanialaboratoryjne.plStrona główna – Badania Laboratoryjne
    WordPressYoast SEOLiteSpeed

Public procurement

48 tenders recorded as contractor: 21 national ($715,691) and 27 EU ($13,560,106).

SubjectAmount
Provision of laboratory services for officers and employees in the field of occupational medicine and for foreigners staying at Strzeżony Ośrodek dla Cudzoziemców in Białystok
–
Laboratory testing services – ZP/TP-13/26
–
Call for tenders for the award of a contract for laboratory diagnostic, serological and microbiological testing, together with the lease of premises for the hospital in Konstancin-Jeziorna, at ul. Wierzejewskiego 12.
–

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2009. In 2026 it is performing 27 contracts with a total value of USD 9.88m. All its contracts were worth USD 76.95m in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Separately contracted healthcare servicesopolskie2USD 1.93m
Preventive health programmesśląskie1USD 1.13m
Preventive health programmesdolnośląskie1USD 1.04m
Preventive health programmesmałopolskie1USD 949.73k
Separately contracted healthcare servicesdolnośląskie1USD 518.57k

NFZ waiting lists

This company's facilities run 5 NFZ waiting lists. Waiting time forecast by NFZ, as of 09.11.2026.

ServiceWaiting time
Genetic testingno wait
Genetic testingno wait
Genetics clinic3 mo 1 wk
Genetics clinic4 mo
Genetics clinic10 mo 3 wk

Trademarks

The company holds 7 active trademarks registered with the Polish Patent Office. 5 applications are pending. 1 mark has expired or was not registered. The first mark was filed in 2023.

MarkNumberClassesStatusProtected until
Diagnostyka+ Więcej dla zdrowia Z.5963419, 42, 44Protected Jan 11, 2036
Mark without a word element (figurative)Z.59432716, 20, 21, 25, 26, 27, 28, 35, 41, 42, 44Protected Nov 25, 2035
KRWINKA MALWINKA Z.59432816, 20, 21, 25, 26, 27, 28, 35, 41, 42, 44Protected Nov 25, 2035
zdrowowieczność (word)Z.5840731, 9, 10, 16, 41, 42, 44, 45Protected May 2, 2035
longevity Z.5650575, 9, 16, 35, 41, 42, 44Protected Jan 19, 2034
MarkProtected until
Diagnostyka+ Więcej dla zdrowia Jan 11, 2036
Mark without a word element (figurative)Nov 25, 2035
KRWINKA MALWINKA Nov 25, 2035
zdrowowieczność (word)May 2, 2035
longevity Jan 19, 2034

Job offers

The company has its own careers page: grupadiagnostyka.pl/kariera.

Authorized Representatives

Dariusz Zowczak age 62 – Vice President of the Management Board
Marta Dorota Rogalska-Kupiec age 54 – Vice President of the Management Board
Jakub Józef Swadźba age 60 – President of the Management Board
Jakub Tatak age 51 – Vice President of the Management Board
Jaromir Pelczarski age 58 – Vice President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action by two members of the management board is required to submit declarations on behalf of the company.

Supervisory board

Aniela Hejnowska age 47 – Supervisory Board Member
Artur Olender age 57 – Supervisory Board Member
Marcin Fryda age 49 – Supervisory Board Member
Grzegorz Jan Głownia age 58 – Supervisory Board Member
Jacek Prusek age 58 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
53.8605%
50%
50%

Capital group

The company is the parent company of a corporate group.

NameOwnership
GenXone S.A.
40.31%
Genomed S.A.
41.17%
Laboratorium Medyczne Optimed Kuriata, Wroński Sp. z o.o.
50%

Bank accounts

Registered as a VAT taxpayer on 2010-07-20.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Dec 2, 2021Financial statement published

Public aid

9 public aid cases recorded, with a total value of $1,282,253.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Investment aid for charging or refuelling infrastructure
–

European Funds

ProjectEU co-financing
System for automated prediction of laboratory tests and optimisation of quality control and analyser workload based on machine learning
$799.2K

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Competitors

Name
Medicover sp. z o.o.
Samodzielny Publiczny Zakład Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi Z.O.Z.
Scanmed S.A.
Roche Diagnostics Polska sp. z o.o.
Alab Laboratoria sp. z o.o.
Polmed S.A.
Synevo sp. z o.o.
Radiometer Solutions sp. z o.o.
Olmed sp. z o.o. sp. k.
J.S. Hamilton Poland sp. z o.o.

FAQ

Last updated: 2026-10-03